Email
Print
Biosimilar Monoclonal Antibody Market - Forecast(2024 - 2030)
1. Biosimilar Monoclonal Antibody Market - Overview
1.1 Definitions and Scope
2. Biosimilar Monoclonal Antibody Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Biosimilar Monoclonal Antibody Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Biosimilar Monoclonal Antibody Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Biosimilar Monoclonal Antibody Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Biosimilar Monoclonal Antibody Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Biosimilar Monoclonal Antibody Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Biosimilar Monoclonal Antibody Market - By Type (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Segment Analysis
8.3.1 Synthetic Chemical
8.3.2 Biopharmaceuticals
9. Biosimilar Monoclonal Antibody Market - By Product (Market Size -$Million / $Billion)
10. Biosimilar Monoclonal Antibody - By Application (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
10.3.1 Chronic Autoimmune Disease
10.3.2 Oncology
11. Biosimilar Monoclonal Antibody- By Geography (Market Size -$Million / $Billion)
11.1 Biosimilar Monoclonal Antibody Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Biosimilar Monoclonal Antibody- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Biosimilar Monoclonal Antibody- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Biosimilar Monoclonal Antibody - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Biosimilar Monoclonal Antibody - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Biosimilar Monoclonal Antibody Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Biosimilar Monoclonal Antibody Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Biosimilar Monoclonal Antibody Market - Key Company List by Country Premium
15. Biosimilar Monoclonal Antibody Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 3Sbio
15.3 Accord Healthcare
15.4 Aet Biotech
15.5 Allergan
15.6 Alvartis Pharma
15.7 Amgen
15.8 Biocon
15.9 Celltrion
15.10 Dr. Reddy'S Laboratory
15.11 Hospira
15.12 Company 12
15.13 Company 13 & More
16.1 Abbreviations
16.2 Sources
17. Biosimilar Monoclonal Antibody Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
1.1 Definitions and Scope
2. Biosimilar Monoclonal Antibody Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Biosimilar Monoclonal Antibody Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Biosimilar Monoclonal Antibody Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Biosimilar Monoclonal Antibody Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Biosimilar Monoclonal Antibody Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Biosimilar Monoclonal Antibody Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Biosimilar Monoclonal Antibody Market - By Type (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Segment Analysis
8.3.1 Synthetic Chemical
8.3.2 Biopharmaceuticals
9. Biosimilar Monoclonal Antibody Market - By Product (Market Size -$Million / $Billion)
10. Biosimilar Monoclonal Antibody - By Application (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
10.3.1 Chronic Autoimmune Disease
10.3.2 Oncology
11. Biosimilar Monoclonal Antibody- By Geography (Market Size -$Million / $Billion)
11.1 Biosimilar Monoclonal Antibody Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Biosimilar Monoclonal Antibody- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Biosimilar Monoclonal Antibody- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Biosimilar Monoclonal Antibody - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Biosimilar Monoclonal Antibody - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Biosimilar Monoclonal Antibody Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Biosimilar Monoclonal Antibody Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Biosimilar Monoclonal Antibody Market - Key Company List by Country Premium
15. Biosimilar Monoclonal Antibody Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 3Sbio
15.3 Accord Healthcare
15.4 Aet Biotech
15.5 Allergan
15.6 Alvartis Pharma
15.7 Amgen
15.8 Biocon
15.9 Celltrion
15.10 Dr. Reddy'S Laboratory
15.11 Hospira
15.12 Company 12
15.13 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. Biosimilar Monoclonal Antibody Market - Appendix16.1 Abbreviations
16.2 Sources
17. Biosimilar Monoclonal Antibody Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Biosimilar Monoclonal Antibody Market, By Type Market 2023-2030 ($M)1.1 Synthetic Chemical Market 2023-2030 ($M) - Global Industry Research
1.2 Biopharmaceuticals Market 2023-2030 ($M) - Global Industry Research
2.Global Biosimilar Monoclonal Antibody Market, By Type Market 2023-2030 (Volume/Units)
2.1 Synthetic Chemical Market 2023-2030 (Volume/Units) - Global Industry Research
2.2 Biopharmaceuticals Market 2023-2030 (Volume/Units) - Global Industry Research
3.North America Biosimilar Monoclonal Antibody Market, By Type Market 2023-2030 ($M)
3.1 Synthetic Chemical Market 2023-2030 ($M) - Regional Industry Research
3.2 Biopharmaceuticals Market 2023-2030 ($M) - Regional Industry Research
4.South America Biosimilar Monoclonal Antibody Market, By Type Market 2023-2030 ($M)
4.1 Synthetic Chemical Market 2023-2030 ($M) - Regional Industry Research
4.2 Biopharmaceuticals Market 2023-2030 ($M) - Regional Industry Research
5.Europe Biosimilar Monoclonal Antibody Market, By Type Market 2023-2030 ($M)
5.1 Synthetic Chemical Market 2023-2030 ($M) - Regional Industry Research
5.2 Biopharmaceuticals Market 2023-2030 ($M) - Regional Industry Research
6.APAC Biosimilar Monoclonal Antibody Market, By Type Market 2023-2030 ($M)
6.1 Synthetic Chemical Market 2023-2030 ($M) - Regional Industry Research
6.2 Biopharmaceuticals Market 2023-2030 ($M) - Regional Industry Research
7.MENA Biosimilar Monoclonal Antibody Market, By Type Market 2023-2030 ($M)
7.1 Synthetic Chemical Market 2023-2030 ($M) - Regional Industry Research
7.2 Biopharmaceuticals Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)2.Canada Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
3.Mexico Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
4.Brazil Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
5.Argentina Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
6.Peru Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
7.Colombia Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
8.Chile Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
9.Rest of South America Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
10.UK Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
11.Germany Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
12.France Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
13.Italy Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
14.Spain Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
15.Rest of Europe Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
16.China Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
17.India Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
18.Japan Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
19.South Korea Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
20.South Africa Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
21.North America Biosimilar Monoclonal Antibody By Application
22.South America Biosimilar Monoclonal Antibody By Application
23.Europe Biosimilar Monoclonal Antibody By Application
24.APAC Biosimilar Monoclonal Antibody By Application
25.MENA Biosimilar Monoclonal Antibody By Application
26.Biocon, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Accord Healthcare, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Aet Biotech, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Amgen, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Celltrion, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Dr. Reddy'S Laboratory, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Hospira, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.3Sbio, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Allergan, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Alvartis Pharma, Sales /Revenue, 2015-2018 ($Mn/$Bn)